Search database
Filter
83
Text search: Contraceptive switching
Featured
Language
Document type
59
18
4
1
1
Countries / Regions
7
6
5
5
4
4
4
4
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
6
4
4
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
46
15
6
4
2
1
Toolboxes
12
3
3
3
2
2
1
1
1
1
 Download
  View PDF
 Add to my

Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis
recommended

World Health Organization WHO (2025) C_WHO
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer. In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN ... more
 Download
  View PDF
 Add to my

Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended

World Health Organization WHO (2025) C_WHO
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
 External Link
 Add to my

Prevention of mother-to-child transmission of HIV

Le Saout, E. International MSF HIV working Group (2020) C2
Internal Document